36410 Federal Register / Vol. 63, No. 128 / Monday, July 6, 1998 / Notices

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Committee on Vital and Health

Statistics: Meeting

Pursuant to the Federal Advisory

Committee Act, the Department of

Health and Human Services announces

the following advisory committee

meeting.

Name: National Committee on Vital and

Health Statistics, Subcommittee on

Populations.

Times and Dates: 9:00 a.m.–5:00 p.m., July

14, 1998; 9:00 a.m.–5:00 p.m., July 15, 1998.

Place: Room 705A, Hubert H. Humphrey

Building, 200 Independence Avenue SW.,

Washington, DC 20201.

Status: Open.

Purpose: The Subcommittee on

Populations will hold a two-day public

meeting to assess the health data needs in the

Pacific insular areas, Puerto Rico, and the

Virgin Islands. The Subcommittee will

examine the relations between these areas

and the Federal government with regard to

the current status of health data collection,

analysis, and utilization, including the

adequacy of available health data and

statistics, as well as health information

systems for assessing population health

needs and health service requirements,

examining the results of Federal public

health spending, and documenting Healthy

People objectives. The Subcommittee intends

to examine impediments to improving health

data collection and use in Pacific insular

areas, Puerto Rico, and the Virgin Islands;

learn about any special considerations

involving privacy and confidentiality;

identify the most critical areas where health

data gathering capabilities are undeveloped

but essential; and develop recommendations

for improving health information systems.

Participants are expected to include

representatives from the Pacific insular areas,

Puerto Rico and the Virgin Islands, as well

as representatives from HHS agencies which

administer programs in these areas, and other

invited federal officials.

For Further Information Contact:

Substantive information about the Committee

as well as a roster of Committee members

may be obtained from James Scanlon,

NCVHS Executive Staff Director, Office of the

Assistant Secretary for Planning and

Evaluation, DHHS, Room 440–D. Humphrey

Building, 200 Independence Avenue SW.,

Washington, DC 20201, telephone (202) 690–

7100, or Marjorie S. Greenberg, Executive

Secretary, NCVHS, NCHS, CDC, Room 1100,

Presidential Building, 6525 Belcrest Road,

Hyattsville, MD 20782, telephone 301/436–

7050. Additional information about the full

Committee is available on the NCVHS

website, where the tentative agenda for the

Subcommittee meeting will also be posted

when available: http://aspe.os.dhhs.gov/

ncvhs

Dated: June 26, 1998.

James Scanlon,

Director, Division of Data Policy.

[FR Doc. 98–17785 Filed 7–2–98; 8:45 am]

BILLING CODE 4151–04–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

[30DAY–17–98]

Agency Forms Undergoing Paperwork

Reduction Act Review

The Centers for Disease Control and

Prevention (CDC) publishes a list of

information collection requests under

review by the Office of Management and

Budget (OMB) in compliance with the

Paperwork Reduction Act (44 U.S.C.

Chapter 35). To request a copy of these

requests, call the CDC Reports Clearance

Officer at (404) 639–7090. Send written

comments to CDC, Desk Officer; Human

Resources and Housing Branch, New

Executive Office Building, Room 10235;

Washington, DC 20503. Written

comments should be received within 30

days of this notice.

Proposed Projects

1. Project Intensive Care

Antimicrobial Resistance Epidemiology

(ICARE), Phase 3—Reinstatement—The

Hospital Infections Program, National

Center for Infectious Diseases, Centers

for Disease Control and Prevention, is

proposing a study to investigate the

relationship between use of

antimicrobial agents and the incidence

of antimicrobial resistance at 40 U.S.

hospitals. The proposed Phase 3 study

of Project ICARE will be very similar to

Phase 2 ICARE with minor revisions.

We hope to enroll 40 hospitals and

address many confounding factors of

antimicrobial resistance. In addition,

these hospitals will serve as a sentinel

surveillance system for different

antimicrobial resistant pathogens, such

as vancomycin resistant staphylococci.

About half of the hospitals have

participated in Phase 2 of Project

ICARE. Participating hospitals will all

be active participants of the CDC’s

National Nosocomial Infections

Surveillance (NNIS) system. Phase 3 of

Project ICARE is a refinement of the

Phase 2 study and will allow

interhospital comparison of data (i.e.,

sending interim reports back to study

hospitals) facilitated by incorporating

differences in culturing frequency, casemix by ICU type and speciality wards

(i.e., internal organization), barrier

precautions, and prescribing practice

policies. Phase 3 will also allow for

valid comparison of attempts at

reducing antimicrobial resistance in

study hospitals (i.e., publish results of

interventions to reduce antimicrobials

resistance at study hospitals). Also, key

parameters of antimicrobial use could

be correlated with antimicrobial

resistance levels and tracked through

the hospital’s quality improvement

indicator process, pharmacy and

therapeutics committee, or medical

staff. Unnecessary use of antimicrobials

may be reduced by these efforts if the

information can be provided to

hospitals. The total annual burden

hours are 6,160.

Form name Number of respondents

No. responses/respondentAvg. burden/response (in hrs.)Total burden

(in hrs.)

Primary contact .......................................................................................... 40 12 1 480

Pharmacy ................................................................................................... 40 48 (median) 2.0 3,840

Microbiology ............................................................................................... 40 60 (median) 0.5 1,200

Isolates ....................................................................................................... 40 80 (maximum) 0.20 640

2. 1999 and 2001 National SchoolBased Youth Risk Behavior Surveys—

National Center for Chronic Disease

Prevention and Health Promotion

(NCCDPHP)—Reinstatement—The

purpose of this request is to renew OMB

clearance for a biennial, national, youth

risk behavior survey. This ongoing

biennial survey is administered to

students attending regular public,

private, and Catholic schools in grades

9–12. The survey addresses priority

health risk behaviors related to the

major preventable causes of mortality,

morbidity, and social problems among

both youth and adults in the U.S.

Previous OMB clearance for these

surveys expired in October of 1997

(OMB No. 1920–0258, expiration 10/97).

OMB clearance for a similar survey

conducted among alternative school

students will expire in December of

1998 (OMB No. 0920–0416, expiration

12/31/98). Data on the health risk
Federal Register / Vol. 63, No. 128 / Monday, July 6, 1998 / Notices 36411

behaviors of adolescents is the focus of

at least 26 national health objectives in

Healthy People 2000: Midcourse Review

and 1995 Revisions. This survey will

provide end-of-decade data to help

measure these objectives, as well as

baseline data to measure many new

national health objectives proposed for

2010. No other national source of data

exists for most of the proposed 2010

objectives that address behaviors of

adolescents. The data also will have

significant implications for policy and

program development for school health

programs nationwide. The total annual

burden hours are 9,173.

Respondents Number of respondents

Number of responses/respondentAvg. burden/

response (in

hrs.)

Total burden

(in hrs.)

Alternative school students .............................................................................. 12,000 1 0.75 9,000

Educating officials ............................................................................................. 345 1 0.50 173

Dated: June 26, 1998.

Charles Gollmar,

Acting Associate Director for Policy Planning

and Evaluation, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 98–17766 Filed 7–2–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Subcommittee for Community Affairs

of the Advisory Committee for EnergyRelated Epidemiologic Research:

Meeting

In accordance with section 10(a)(2) of

the Federal Advisory Committee Act

(Pub. L. 92–463), the Centers for Disease

Control and Prevention (CDC)

announces the following subcommittee

meeting.

Name: Subcommittee for Community

Affairs of the Advisory Committee for

Energy-Related Epidemiologic Research.

Times and Dates: 8:30 a.m.–4:45 p.m., July

23, 1998; 8:15 a.m.–12 noon, July 24, 1998.

Place: The Grove Hotel, 245 South Capitol

Boulevard, Boise, Idaho 83702, telephone

208/333–8000, FAX 208/333–8800.

Status: Open to the public, limited only by

the space available. The meeting room

accommodates approximately 50 people.

Purpose: This subcommittee will advise

the Advisory Committee for Energy-Related

Epidemiologic Research (ACERER) on

matters related to community needs and will

report back to the agency through ACERER.

Matters to be Discussed: Agenda items

include: discussions on the status of current

federal health agencies’ responses to the

National Cancer Institute (NCI) I–131 fallout

study and the feasibility of additional

responses that include, but not limited to,

notification, education, screening, medical

monitoring, additional dose assessment

(other radionuclides), and epidemiology; and

the history and progress of the Idaho

National Engineering and Environmental

Laboratory (INEEL) dose reconstruction

project with a focus on the process of

discovering, accessing, and assembling

documentation on the emissions of

radionuclides and chemicals from INEEL

facilities.

Agenda items are subject to change as

priorities dictate.

Contact Person for More Information: Mr.

Steven Adams, Public Health Advisor,

Radiation Studies Branch, Division of

Environmental Hazards and Health Effects,

NCEH, CDC, 4770 Buford Highway, NE,

M/S F–35, Atlanta, Georgia 30341–3724,

telephone 770/488–7040, FAX 770/488–

7044.

Dated: June 29, 1998.

Carolyn J. Russell,

Director, Management Analysis and Services

Office, Centers for Disease Control and

Prevention (CDC).

[FR Doc. 98–17764 Filed 7–2–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

National Vaccine Advisory Committee;

Notice of Meeting

Name: National Vaccine Advisory

Committee (NVAC) Immunization

Registries Workgroup on Privacy and

Confidentiality.

Time and Date: 8:30 a.m.–12:30 p.m.,

July 16, 1998.

Name: NVAC Immunization

Registries Workgroup on Technical and

Operational Challenges.

Time and Date: 1:30 p.m.–5:30 p.m.,

July 16, 1998.

Name: NVAC Immunization

Registries Workgroup on Ensuring

Provider Participation.

Time and Date: 8:30 a.m.–12:30 p.m.,

July 17, 1998.

Name: NVAC Immunization

Registries Workgroup on Resource

Issues.

Time and Date: 1:30 p.m.–5:30 p.m.,

July 17, 1998.

Place: Marriott Marquis, 265

Peachtree Center, Atlanta, Georgia,

telephone (404) 521–0000.

Status: Open to the public, limited

only by space availability. The meeting

room accommodates approximately 200

people.

Purpose: During a White House

Ceremony on July 23, 1997, the

President directed the Secretary of

Health and Human Services (HHS) to

work with the States on integrated

immunization registries. As a result,

NVAC has formed a Workgroup, staffed

by the National Immunization Program

(NIP), that will gather information for

development of a National

Immunization Registry Plan of Action.

To assist in the formulation of a work

plan, a series of public meetings relating

to (1) privacy and confidentiality; (2)

resource issues; (3) technical and

operational challenges; and (4) ensuring

provider participation, will be held

throughout the Nation. These meetings

will provide an opportunity for input

from all partners which include state

and local public health agencies,

professional organizations of private

health agencies, managed care

organizations (MCOs), employer-funded

health care plans, vaccine

manufacturers and developers, vendors

and developers of medical information

systems, information standards

development organizations, parents,

social welfare agencies, legislators,

privacy and consumer interest groups,

and other representatives of the public

at large.

For each meeting, the Workgroup is

inviting experts to address the four

specific issues outlined above. Expert

speakers are being asked to respond to

the questions outlined below in writing,

make brief oral presentations, and to

respond to additional questions from

the Workgroup.

Members of the public who wish to

provide comments may do so in the

form of written statements, to be

received by the completion of the last

meeting, addressed as follows: NIP/

CDC, Data Management Division, 1600

Clifton Road, NE, M/S E–62, Atlanta,

Georgia 30333.

There will be a period of time during

the agenda for members of the public to

make oral statements, not exceeding 3